| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |